Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2003
03/05/2003EP1286995A1 2,7-naphthyridine derivatives
03/05/2003EP1286992A1 Piperidyindoles as serotonin receptor ligands
03/05/2003EP1286989A2 Prodrug of an ice inhibitor
03/05/2003EP1286986A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286974A2 Medicament for viral diseases
03/05/2003EP1286973A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
03/05/2003EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents
03/05/2003EP1286962A1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
03/05/2003EP1286693A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
03/05/2003EP1286691A2 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
03/05/2003EP1286690A2 Use of alpha-msh and epo for preventing or treating ischemic conditions
03/05/2003EP1286681A1 Irradiation of ispaghula
03/05/2003EP1286670A2 Use of therapeutic benzamide derivatives
03/05/2003EP1286669A2 Methods for prevention of ulcers and improving physiological performance
03/05/2003EP1286668A2 Pharmaceutical combinations and their use in treating gastrointestinal disorders
03/05/2003EP1286660A1 Pharmaceutical composition in liquid form for oral administration of an active principle, with unpleasant, in particular bitter, taste
03/05/2003EP1286591A1 Treating smooth muscle hyperactivity with (r)-oxybutynin and (r)- desethyloxybutynin
03/05/2003EP1169316B1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
03/05/2003EP1140923B1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates
03/05/2003EP1115719B1 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/05/2003EP1069907A4 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS
03/05/2003EP1042278B1 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
03/05/2003EP0991641B1 Crystalline form of omeprazole sodium salt
03/05/2003EP0969819B1 New crystalline form of omeprazole
03/05/2003EP0966447B1 Small molecules useful in the treatment of inflammatory disease
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003EP0801067B1 Novel quinuclidine derivatives and medicinal composition thereof
03/05/2003EP0782441B1 Pharmaceutical control of inflammation
03/05/2003EP0690863B1 Tetracyclic compounds as dopamine agonists
03/05/2003EP0667784B1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
03/05/2003CN1400975A 嘌呤衍生物 Purine derivatives
03/05/2003CN1400973A Novel biarylcarboxamides
03/05/2003CN1400970A Substituted arylpyrazines
03/05/2003CN1400968A Method for preparing alpha sulfonyl hydroxamic acid derivatives
03/05/2003CN1400902A Oral formulation comprising an inhibitor compound of the ileal bile transport and on HMG CO-A reductase inhibitor
03/05/2003CN1400900A Remedies or preventives for digestive diseases containing diaminotrifluoromethylpyridine derivatives
03/05/2003CN1400898A 回旋酶抑制剂及其用途 Gyrase inhibitors and their use
03/05/2003CN1400871A Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability of undesired permeability of the
03/05/2003CN1400870A Improved pediatric formula and methods for providing nutrition and improving tolerance
03/05/2003CN1400869A Inulin products with improved nutritional properties
03/05/2003CN1400005A Chinese medicine for boosting brain and supplementing kidney and its preparation method
03/05/2003CN1400003A Medicine composition for curing hepatitis
03/05/2003CN1400001A Medicine for curing cough and asthma
03/05/2003CN1399992A Medicine for curing gastritis, gastric and duodenal ulcer
03/05/2003CN1399990A Health-care product for curing gastric ulcer and duodenal ulcer and its preparation method
03/05/2003CN1399981A Prescription of protein medicine for curing liver cancer and its preparation method
03/05/2003CN1399975A Medicine for curing peptic ulcer and its preparation method
03/05/2003CN1399974A Sanhuangweikang medicine for curing gastropathy
03/05/2003CN1399970A Preparation method of silkworm dropping soluble preparation
03/05/2003CN1399963A Diammonium glycyrrhizanate transfusion preparation
03/05/2003CN1399961A Medicine for curing toothache
03/05/2003CN1399914A Body-building face-nourishing nutrient liquor
03/05/2003CN1102596C 5H-thiazole [3,2-a] pyrmidine derivatives
03/05/2003CN1102573C Aryl or heteroaryl substd, 3,4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs having bioactivity of visual pigmentoid
03/05/2003CN1102394C Health care product containing lacteinand its preparing method
03/05/2003CA2421283A1 Novel mmp-2 derivatives for use as inhibitors of integrin .alpha.v.beta.3
03/04/2003US6528623 Antibodies that specifically bind ACT-4-L-h-1 ligand
03/04/2003US6528542 Adjustment concentration
03/04/2003US6528541 Administering to the cow at least one of an ester of methionine, an ester of methionine amide, and an ester of hydroxy analogue of methionine, or salt of atleast one ester to increase milk production
03/04/2003US6528522 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
03/04/2003US6528521 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
03/04/2003US6528515 Beta-2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (beta -FTC) and penciclovir
03/04/2003US6528512 Cytokine specific binding protein;
03/04/2003US6528509 Pyrazole compositions useful as inhibitors of ERK
03/04/2003US6528508 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli
03/04/2003US6528504 Compounds such as (R)-5,11-dihydro-5-(1-(4-methoxyphenethyl)-piperidine-2-ylmethyl) -dibenzo(b,e)(1,4) oxazepine are useful for treating or preventing abnormal motor functions of gastrointestinal tracts, e.g., irritable bowel syndrome.
03/04/2003US6528498 Selection and/or enhancement of resident microorganisms in the gastrointestinal tract
03/04/2003US6528096 Carrier mixed with additives having lubricant properties for preparing powdery pharmaceutical compositions for inhalation
03/04/2003US6528055 Polypeptide for use in the diagnosis, treatment and prevention of infections, immune response defects and autoimmune diseases
03/04/2003US6528038 An immune response directed against Porphyromonas gingivalis. The composition includes a suitable adjuvant and/or acceptable carrier and one substantially purified P. gingivalis immunogen. The immunogen is selected from the group consisting
03/04/2003CA2218913C Substituted oximes, hydrazones and olefins as neurokinin antagonists
03/01/2003WO2003000027A2 Blocking peptide for inflammatory cell secretion
03/01/2003CA2452123A1 Blocking peptide for inflammatory cell secretion
02/2003
02/27/2003WO2003016916A1 Identification and isolation of somatic stem cells and uses thereof
02/27/2003WO2003016549A2 Nucleic-acid associated proteins
02/27/2003WO2003016544A1 Process for producing 1,4-dihydroxy-2-naphthoic acid
02/27/2003WO2003016530A1 Novel protein and its dna
02/27/2003WO2003016505A2 Kgf polypeptide compositions
02/27/2003WO2003016493A2 Transporters and ion channels
02/27/2003WO2003016468A2 Antagonistic anti-htnfsf13b human antibodies
02/27/2003WO2003016351A2 N - cam related compounds modulating cell groth
02/27/2003WO2003016314A1 1-alkyl 0r 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
02/27/2003WO2003016310A1 Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
02/27/2003WO2003016279A1 Fused-polycyclic compounds
02/27/2003WO2003016277A1 Cyclohept`b!indole derivatives as spla2 inhibitors
02/27/2003WO2003016270A2 Selective estrogen receptor modulators
02/27/2003WO2003016265A1 Cyclic compound and ppar agonist
02/27/2003WO2003015871A2 Method and apparatus for rapid determination of ligand-protein binding using charcoal adsorption
02/27/2003WO2003015817A2 Oral immunoglobulin treatment for inflammatory bowel disease
02/27/2003WO2003015805A1 Composition for removal of toxins
02/27/2003WO2003015801A1 Hemostatic material, complex hemostatic material and method of hemostasis
02/27/2003WO2003015799A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate
02/27/2003WO2003015797A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine
02/27/2003WO2003015794A1 Methods and compositions for treating apoptosis associated disorders
02/27/2003WO2003015787A1 Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine
02/27/2003WO2003015784A1 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
02/27/2003WO2003015776A1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
02/27/2003WO2003015765A1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect
02/27/2003WO2003015761A1 Selective estrogen receptor modulators
1 ... 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 ... 1258